GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dyadic International Inc (NAS:DYAI) » Definitions » Cyclically Adjusted PB Ratio

Dyadic International (Dyadic International) Cyclically Adjusted PB Ratio : 1.13 (As of Apr. 29, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Dyadic International Cyclically Adjusted PB Ratio?

As of today (2024-04-29), Dyadic International's current share price is $1.4556. Dyadic International's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1.29. Dyadic International's Cyclically Adjusted PB Ratio for today is 1.13.

The historical rank and industry rank for Dyadic International's Cyclically Adjusted PB Ratio or its related term are showing as below:

DYAI' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.95   Med: 2.82   Max: 8.15
Current: 1.16

During the past years, Dyadic International's highest Cyclically Adjusted PB Ratio was 8.15. The lowest was 0.95. And the median was 2.82.

DYAI's Cyclically Adjusted PB Ratio is ranked better than
61.47% of 641 companies
in the Biotechnology industry
Industry Median: 1.74 vs DYAI: 1.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dyadic International's adjusted book value per share data for the three months ended in Dec. 2023 was $0.204. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.29 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dyadic International Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Dyadic International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dyadic International Cyclically Adjusted PB Ratio Chart

Dyadic International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.44 4.48 3.57 0.98 1.25

Dyadic International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.42 1.51 1.49 1.25

Competitive Comparison of Dyadic International's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Dyadic International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dyadic International's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dyadic International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dyadic International's Cyclically Adjusted PB Ratio falls into.



Dyadic International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Dyadic International's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.4556/1.29
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dyadic International's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Dyadic International's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.204/129.4194*129.4194
=0.204

Current CPI (Dec. 2023) = 129.4194.

Dyadic International Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.075 98.326 0.099
201403 0.034 99.695 0.044
201409 0.000 100.428 0.000
201412 -0.066 99.070 -0.086
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 -0.018 100.392 -0.023
201512 1.831 99.792 2.375
201603 1.825 100.470 2.351
201606 1.844 101.688 2.347
201609 1.836 101.861 2.333
201612 1.782 101.863 2.264
201703 1.897 102.862 2.387
201706 1.854 103.349 2.322
201709 1.804 104.136 2.242
201712 1.764 104.011 2.195
201803 1.704 105.290 2.095
201806 1.650 106.317 2.009
201809 1.606 106.507 1.951
201812 1.589 105.998 1.940
201903 1.519 107.251 1.833
201906 1.424 108.070 1.705
201909 1.369 108.329 1.636
201912 1.311 108.420 1.565
202003 1.247 108.902 1.482
202006 1.168 108.767 1.390
202009 1.091 109.815 1.286
202012 1.035 109.897 1.219
202103 0.932 111.754 1.079
202106 0.825 114.631 0.931
202109 0.780 115.734 0.872
202112 0.651 117.630 0.716
202203 0.580 121.301 0.619
202206 0.480 125.017 0.497
202209 0.443 125.227 0.458
202212 0.388 125.222 0.401
202303 0.375 127.348 0.381
202306 0.312 128.729 0.314
202309 0.266 129.860 0.265
202312 0.204 129.419 0.204

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dyadic International  (NAS:DYAI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Dyadic International Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Dyadic International's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dyadic International (Dyadic International) Business Description

Traded in Other Exchanges
N/A
Address
140 Intracoastal Pointe Drive, Suite 404, Jupiter, FL, USA, 33477
Dyadic International Inc is a global biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Executives
Ronen Tchelet officer: VP of Research and Bus. Dvlpmt 140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Mark A Emalfarb director, 10 percent owner, officer: President, CEO & Chairman C/O DYADIC INTERNATIONAL, INC., 140 INTRACOASTAL POINT DRIVE, SUITE 404, JUPITER FL 33477-5094
Joseph P Hazelton officer: Chief Business Officer 140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER FL 33477
Francisco Trust Under Agreement Dated February 28, 1996 10 percent owner C/O ROBERT S. LEVIN, ESQ., TRUSTEE, 180 NORTH LASALLE STREET, SUITE 3200, CHICAGO IL 60601
Patrick K. Lucy director C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Matthew S. Jones officer: Managing Dir of BD & Licensing 140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Seth Herbst director 140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Barry Buckland director C/O DYADIC INTERNATIONAL, INC., 140 INTERCOASTAL POINTE DR SUITE 404, JUPITER FL 33477
Ping Wang Rawson officer: Chief Financial Officer 140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Michael P. Tarnok director KERYX BIOPHARMACEUTICALS, INC., 750 LEXINGTON AVENUE, NEW YORK NY 10022
Arindam Bose director 4452 BELTWAY DRIVE, ADDISON TX 75001
Jack Kaye director C/O KERYX BIOPHARMACEUTICALS, 750 LEXINGTON AVENUE, NEW YORK X1 10022
Tom Juda 10 percent owner 410 S LUCERNE BLVD, LOS ANGELES CA 90020
John Steven Emerson 10 percent owner 1522 ENSLEY AVENUE, LOS ANGELES CA 90024
Nancy Juda 10 percent owner 410 S LUCERNE BLVD, LOS ANGELES CA 90020

Dyadic International (Dyadic International) Headlines